Robert Jenq
Member of Scientific Advisory BoardDr. Robert Jenq, M.D., is Member of Scientific Advisory Board of MaaT Pharma, SA from May 2020. He is Member of Scientific Advisory Board at Kaleido BioSciences, Inc. since 2019. He served as Member of Scientific Advisory Board at Seres Therapeutics, Inc. Dr. Jenq is an Assistant Professor in the Department of Genomic Medicine and the Department of Stem Cell Transplantation, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, Houston, TX. His laboratory examines the impact of the microbiome on cancer treatment, focusing in particular on bone marrow transplantation and cancer immunotherapies. Data from his group and others has demonstrated that the microbiome can be a potent modulator of cancer treatment efficacy and toxicity. Using a multidisciplinary approach, he hopes to develop and translate strategies to target the microbiome to further increase treatment efficacy while reducing toxicities. Dr. Jenq holds an M.D. from Oregon Health and Science University.
Positions
- Company NameKaleido Biosciences, Inc.Stock CodeKLDOPositionMember of Scientific Advisory Board
